Search research articles
Contact Us
Filters
Showing results (221-230 of 251) with videos related to
Page
of 26
Sort By:
Neurogastroenterology and Motility
|
September 5, 2023
Long-term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO-3 study
Anthony J Lembo, Keith A Friedenberg, Ronald P Fogel, et al.
Gastrointestinal Endoscopy
|
May 11, 2000
Role of EUS in the preoperative localization of insulinomas compared with spiral CT
J C Ardengh, P Rosenbaum, A J Ganc, et al.
Informatics for Health & Social Care
|
October 14, 2008
The pharmaceutical management system at Shade Tree Family Clinic: a medical student-run free clinic's experience
Benjamin P Rosenbaum, Sanjay G Patel, Dana L Guyer, et al.
The Journal of Urology
|
October 30, 2010
Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration
Soumendra N Datta, Alexander Roosen, Antony Pullen, et al.
Journal of the American Society of Nephrology : JASN
|
February 5, 2017
Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis
Geoffrey A Block, David P Rosenbaum, Maria Leonsson-Zachrisson, et al.
Kidney360
|
October 19, 2023
Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study
Arnold L Silva, Glenn M Chertow, German T Hernandez, et al.
Neurosurgery
|
June 4, 2015
National Trends and In-hospital Complication Rates in More Than 1600 Hemispherectomies From 1988 to 2010: A Nationwide Inpatient Sample Study
Sumeet Vadera, Sandra D Griffith, Benjamin P Rosenbaum, et al.
Kidney360
|
April 4, 2022
Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)
Geoffrey A Block, Anthony J Bleyer, Arnold L Silva, et al.
Kidney360
|
May 7, 2026
Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)
Geoffrey A Block, Anthony J Bleyer, Arnold L Silva, et al.
Neurosurgical Focus
|
June 3, 2014
Variations in cost calculations in spine surgery cost-effectiveness research
Matthew D Alvin, Jacob A Miller, Daniel Lubelski, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 251) with videos related to
Sort By:
Page
of 26
Neurogastroenterology and Motility
|
September 5, 2023
Long-term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO-3 study
Anthony J Lembo, Keith A Friedenberg, Ronald P Fogel, et al.
Gastrointestinal Endoscopy
|
May 11, 2000
Role of EUS in the preoperative localization of insulinomas compared with spiral CT
J C Ardengh, P Rosenbaum, A J Ganc, et al.
Informatics for Health & Social Care
|
October 14, 2008
The pharmaceutical management system at Shade Tree Family Clinic: a medical student-run free clinic's experience
Benjamin P Rosenbaum, Sanjay G Patel, Dana L Guyer, et al.
The Journal of Urology
|
October 30, 2010
Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration
Soumendra N Datta, Alexander Roosen, Antony Pullen, et al.
Journal of the American Society of Nephrology : JASN
|
February 5, 2017
Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis
Geoffrey A Block, David P Rosenbaum, Maria Leonsson-Zachrisson, et al.
Kidney360
|
October 19, 2023
Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study
Arnold L Silva, Glenn M Chertow, German T Hernandez, et al.
Neurosurgery
|
June 4, 2015
National Trends and In-hospital Complication Rates in More Than 1600 Hemispherectomies From 1988 to 2010: A Nationwide Inpatient Sample Study
Sumeet Vadera, Sandra D Griffith, Benjamin P Rosenbaum, et al.
Kidney360
|
April 4, 2022
Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)
Geoffrey A Block, Anthony J Bleyer, Arnold L Silva, et al.
Kidney360
|
May 7, 2026
Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)
Geoffrey A Block, Anthony J Bleyer, Arnold L Silva, et al.
Neurosurgical Focus
|
June 3, 2014
Variations in cost calculations in spine surgery cost-effectiveness research
Matthew D Alvin, Jacob A Miller, Daniel Lubelski, et al.
Page
of 26